Aditxt Financials
| ADTX Stock | USD 1.35 0.03 2.17% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.25 | 0.267 |
|
|
Investors should never underestimate Aditxt's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aditxt's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aditxt Inc.
Net Income |
|
Aditxt | Select Account or Indicator |
Understanding current and past Aditxt Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aditxt's financial statements are interrelated, with each one affecting the others. For example, an increase in Aditxt's assets may result in an increase in income on the income statement.
The data published in Aditxt's official financial statements typically reflect Aditxt's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Aditxt's quantitative information. For example, before you start analyzing numbers published by Aditxt accountants, it's essential to understand Aditxt's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Please note, the imprecision that can be found in Aditxt's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aditxt Inc. Check Aditxt's Beneish M Score to see the likelihood of Aditxt's management manipulating its earnings.
Aditxt Stock Summary
Aditxt competes with Neurobo Pharmaceuticals, Dermata Therapeutics, Unicycive Therapeutics, Revelation Biosciences, and Palisade Bio. Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Aditxt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 58 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US0070251097 |
| CUSIP | 007025109 007025505 007025604 |
| Location | Virginia; U.S.A |
| Business Address | 737 North Fifth |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.aditxt.com |
| Phone | 650 870 1200 |
| Currency | USD - US Dollar |
Aditxt Key Financial Ratios
Aditxt's financial ratios allow both analysts and investors to convert raw data from Aditxt's financial statements into concise, actionable information that can be used to evaluate the performance of Aditxt over time and compare it to other companies across industries.| Return On Equity | -8.38 | ||||
| Operating Margin | (144.77) % | ||||
| Price To Sales | 6.69 X | ||||
| Revenue | 645.18 K | ||||
| Gross Profit | 166.94 K |
Aditxt Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 123.5K | 13.1M | 16.7M | 10.7M | 44.6M | 46.8M | |
| Other Current Liab | 962.7K | 248.1K | 1.8M | 2.1M | 158.6K | 150.7K | |
| Net Tangible Assets | (2.9M) | 10.7M | 10.0M | 5.1M | 5.9M | 3.9M | |
| Net Debt | 161.5K | (8.7M) | (3.2M) | 613.2K | 18.1M | 19.0M | |
| Retained Earnings | (11.7M) | (20.9M) | (67.4M) | (95.0M) | (127.7M) | (121.4M) | |
| Accounts Payable | 1.8M | 241.6K | 1.6M | 2.0M | 8.6M | 9.0M | |
| Cash | 4.1K | 10.5M | 7.9M | 2.8M | 97.1K | 92.2K | |
| Total Liab | 3.0M | 2.1M | 6.5M | 5.5M | 28.5M | 30.0M | |
| Net Invested Capital | (2.7M) | 11.0M | 11.0M | 5.6M | 32.2M | 33.8M | |
| Total Current Assets | 4.1K | 11.0M | 9.4M | 4.7M | 6.9M | 5.1M | |
| Net Working Capital | (3.0M) | 9.8M | 5.8M | 1.1M | (19.0M) | (18.0M) | |
| Common Stock | 3.9K | 13.1K | 44.5K | 4.3K | 1.3K | 1.3K | |
| Short Long Term Debt | 165.6K | 587.6K | 700.4K | 410.0K | 16.2M | 17.0M | |
| Capital Stock | 3.9K | 13.1K | 44.5K | 4.3K | 1.3K | 1.3K | |
| Short Term Debt | 165.6K | 978.8K | 1.8M | 1.5M | 17.2M | 18.0M |
Aditxt Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 1.9K | 310.1K | 1.9M | 2.3M | 6.4M | 6.7M | |
| Operating Income | (5.9M) | (8.9M) | (27.4M) | (24.9M) | (26.1M) | (24.8M) | |
| Ebit | (5.9M) | (8.9M) | (27.4M) | (24.9M) | (26.1M) | (24.8M) | |
| Income Before Tax | (5.8M) | (9.1M) | (46.4M) | (27.6M) | (32.4M) | (30.8M) | |
| Net Income | (5.8M) | (9.5M) | (48.3M) | (28.2M) | (32.4M) | (30.8M) | |
| Net Interest Income | (1.9K) | (309.5K) | (1.9M) | (2.2M) | (6.4M) | (6.1M) | |
| Interest Income | 1.9K | 563.0 | 3.1K | 57.3K | 10.2K | 9.7K | |
| Research Development | 175.4K | 938.0K | 5.0M | 7.3M | 7.1M | 3.9M | |
| Ebitda | (5.9M) | (8.9M) | (27.0M) | (24.3M) | (25.5M) | (26.8M) |
Aditxt Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Aditxt Inc. It measures of how well Aditxt is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Aditxt brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Aditxt had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Aditxt has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (111.6K) | 10.5M | (2.6M) | (5.1M) | (2.7M) | (2.5M) | |
| Net Borrowings | 2.0K | (340.6K) | 2.9M | (812.4K) | (934.2K) | (887.5K) | |
| Net Income | (5.8M) | (9.1M) | (46.4M) | (27.6M) | (32.4M) | (30.8M) | |
| End Period Cash Flow | 4.1K | 10.5M | 7.9M | 2.8M | 97.1K | 92.2K | |
| Change To Netincome | 4.2M | 3.2M | 21.6M | 3.7M | 4.2M | 6.8M | |
| Free Cash Flow | (464.4K) | (7.4M) | (23.3M) | (22.8M) | (18.6M) | (19.5M) | |
| Other Non Cash Items | 533.3K | 300K | 1.8M | 2.1M | 9.7M | 10.2M |
Aditxt Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aditxt's current stock value. Our valuation model uses many indicators to compare Aditxt value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aditxt competition to find correlations between indicators driving Aditxt's intrinsic value. More Info.Aditxt Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Aditxt's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aditxt's earnings, one of the primary drivers of an investment's value.Aditxt Inc Systematic Risk
Aditxt's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aditxt volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Aditxt Inc correlated with the market. If Beta is less than 0 Aditxt generally moves in the opposite direction as compared to the market. If Aditxt Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aditxt Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aditxt is generally in the same direction as the market. If Beta > 1 Aditxt moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aditxt Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aditxt's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aditxt growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Aditxt July 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aditxt help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aditxt Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aditxt Inc based on widely used predictive technical indicators. In general, we focus on analyzing Aditxt Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aditxt's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 63.97 | |||
| Value At Risk | (8.99) | |||
| Potential Upside | 6.8 |
Additional Tools for Aditxt Stock Analysis
When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.